Prescribing information

 

_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

This on-demand webinar series explores the changing face of Melanoma treatment as a result of the global COVID-19 pandemic. It will assess how COVID-19 has impacted Melanoma practices and patient outcomes in the short term, as well as how it may shape treatment decisions and service provision for years to come.

 

PTSD, post-traumatic stress disorder, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2.

Rate this content: 
No votes yet
UK | September 2021 | 113667
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]